mianserin has been researched along with Sexual Dysfunctions, Psychological in 15 studies
Mianserin: A tetracyclic compound with antidepressant effects. It may cause drowsiness and hematological problems. Its mechanism of therapeutic action is not well understood, although it apparently blocks alpha-adrenergic, histamine H1, and some types of serotonin receptors.
mianserin : A dibenzoazepine (specifically 1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine) methyl-substituted on N-2. Closely related to (and now mostly superseded by) the tetracyclic antidepressant mirtazapinean, it is an atypical antidepressant used in the treatment of depression throughout Europe and elsewhere.
Sexual Dysfunctions, Psychological: Disturbances in sexual desire and the psychophysiologic changes that characterize the sexual response cycle and cause marked distress and interpersonal difficulty. (APA, DSM-IV, 1994)
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study randomly assigned FGA-treated patients with schizophrenia to receive either an add-on mirtazapine (n = 20) or a placebo (n = 19) for 6 weeks." | 7.85 | Add-on mirtazapine improves orgasmic functioning in patients with schizophrenia treated with first-generation antipsychotics. ( Burkin, M; Joffe, G; Stenberg, JH; Terevnikov, V; Tiihonen, J, 2017) |
| "Nineteen patients (12 women and 7 men), with SSRI-induced sexual dysfunction who were in remission from major depressive disorder (total Hamilton Rating Scale for Depression [HAM-D] score < or = 10), were switched to open-label mirtazapine for up to 6 weeks." | 5.09 | Mirtazapine substitution in SSRI-induced sexual dysfunction. ( Delgado, P; Gelenberg, AJ; Laukes, C; McGahuey, C; Moreno, F; Okayli, G; Zentner, L, 2000) |
| "This study randomly assigned FGA-treated patients with schizophrenia to receive either an add-on mirtazapine (n = 20) or a placebo (n = 19) for 6 weeks." | 3.85 | Add-on mirtazapine improves orgasmic functioning in patients with schizophrenia treated with first-generation antipsychotics. ( Burkin, M; Joffe, G; Stenberg, JH; Terevnikov, V; Tiihonen, J, 2017) |
| "Mirtazapine augmentation is a good choice for the treatment of SSRI-induced sexual dysfunction, and the results are typically seen later after 4-8 weeks." | 2.73 | Mirtazapine augmentation in depressed patients with sexual dysfunction due to selective serotonin reuptake inhibitors. ( Bozkurt, A; Cansever, A; Doruk, A; Karlidere, T; Ozgen, F; Ozmenler, NK; Ozsahin, A; Sutcigil, L; Uzun, O; Yetkin, S, 2008) |
| "Mirtazapine has a pharmacological profile expected to result in a lack of sexual dysfunction." | 1.33 | Assessment of sexual functioning in depressed patients treated with mirtazapine: a naturalistic 6-month study. ( Arias, F; Carrasco, JL; Díaz, M; Ferrando, L; Ibáñez, A; Montes, JM; Pelegrín, C; Saiz-Ruiz, J; Vicente, F; Viñas, R, 2005) |
| "Mianserin was added to on-going treatment at low doses, 7." | 1.31 | Relief of serotonin selective reuptake inhibitor induced sexual dysfunction with low-dose mianserin in patients with traumatic brain injury. ( Dolberg, OT; Gross, Y; Klag, E; Schreiber, S, 2002) |
| "Mianserin 15 mg was coadministered to 15 male subjects with new-onset sexual dysfunction who were under treatment with SRIs." | 1.30 | Mianserin, a 5-HT2a/2c and alpha 2 antagonist, in the treatment of sexual dysfunction induced by serotonin reuptake inhibitors. ( Aizenberg, D; Granek, M; Gur, S; Jeczmien, P; Weizman, A; Zemishlany, Z, 1997) |
| "Mirtazapine is an atypical antidepressant with alpha 2 adrenergic antagonist and serotonin 5-HT2 and 5-HT3 receptor-blocking activity." | 1.30 | Sexual functioning in depressed outpatients taking mirtazapine. ( Boyarsky, BK; Haque, W; Hirschfeld, RM; Rouleau, MR, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (40.00) | 18.2507 |
| 2000's | 7 (46.67) | 29.6817 |
| 2010's | 2 (13.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Terevnikov, V | 1 |
| Stenberg, JH | 1 |
| Tiihonen, J | 1 |
| Burkin, M | 1 |
| Joffe, G | 1 |
| Schutters, SI | 1 |
| van Megen, HJ | 1 |
| Van Veen, JF | 1 |
| Schruers, KR | 1 |
| Westenberg, HG | 1 |
| Pallanti, S | 1 |
| Quercioli, L | 1 |
| Bruscoli, M | 1 |
| Saiz-Ruiz, J | 1 |
| Montes, JM | 1 |
| Ibáñez, A | 1 |
| Díaz, M | 1 |
| Vicente, F | 1 |
| Pelegrín, C | 1 |
| Viñas, R | 1 |
| Arias, F | 1 |
| Carrasco, JL | 1 |
| Ferrando, L | 1 |
| Clayton, AH | 1 |
| Montejo, AL | 1 |
| Ravindran, LN | 1 |
| Eisfeld, BS | 1 |
| Kennedy, SH | 1 |
| Ozmenler, NK | 1 |
| Karlidere, T | 1 |
| Bozkurt, A | 1 |
| Yetkin, S | 1 |
| Doruk, A | 1 |
| Sutcigil, L | 1 |
| Cansever, A | 1 |
| Uzun, O | 1 |
| Ozgen, F | 1 |
| Ozsahin, A | 1 |
| Aizenberg, D | 1 |
| Gur, S | 1 |
| Zemishlany, Z | 1 |
| Granek, M | 1 |
| Jeczmien, P | 1 |
| Weizman, A | 1 |
| Berigan, TR | 1 |
| Harazin, JS | 1 |
| Farah, A | 1 |
| Boyarsky, BK | 1 |
| Haque, W | 1 |
| Rouleau, MR | 1 |
| Hirschfeld, RM | 2 |
| Davis, J | 1 |
| Barkin, RL | 1 |
| Gelenberg, AJ | 1 |
| McGahuey, C | 1 |
| Laukes, C | 1 |
| Okayli, G | 1 |
| Moreno, F | 1 |
| Zentner, L | 1 |
| Delgado, P | 1 |
| Dolberg, OT | 1 |
| Klag, E | 1 |
| Gross, Y | 1 |
| Schreiber, S | 1 |
2 reviews available for mianserin and Sexual Dysfunctions, Psychological
| Article | Year |
|---|---|
Major depressive disorder, antidepressants, and sexual dysfunction.
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; B | 2006 |
Care of the sexually active depressed patient.
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Bupropion; Clinical Tria | 1999 |
5 trials available for mianserin and Sexual Dysfunctions, Psychological
| Article | Year |
|---|---|
Paroxetine augmentation in patients with generalised social anxiety disorder, non-responsive to mirtazapine or placebo.
Topics: Adrenergic alpha-Antagonists; Adult; Anxiety Disorders; Double-Blind Method; Drug Therapy, Combinati | 2011 |
Response acceleration with mirtazapine augmentation of citalopram in obsessive-compulsive disorder patients without comorbid depression: a pilot study.
Topics: Adult; Age of Onset; Antidepressive Agents, Tricyclic; Citalopram; Comorbidity; Depressive Disorder; | 2004 |
Mirtazapine augmentation in depressed patients with sexual dysfunction due to selective serotonin reuptake inhibitors.
Topics: Adult; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Male; Mianserin; Middl | 2008 |
Relief of SSRI-induced sexual dysfunction with mirtazapine treatment.
Topics: Adult; Antidepressive Agents, Tricyclic; Anxiety Disorders; Drug Therapy, Combination; Female; Fluox | 1999 |
Mirtazapine substitution in SSRI-induced sexual dysfunction.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Depressive Disorder; Female; Humans; Irritable Mood; Male | 2000 |
8 other studies available for mianserin and Sexual Dysfunctions, Psychological
| Article | Year |
|---|---|
Add-on mirtazapine improves orgasmic functioning in patients with schizophrenia treated with first-generation antipsychotics.
Topics: Adult; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Drug Therapy, Combination; Female; Hu | 2017 |
Assessment of sexual functioning in depressed patients treated with mirtazapine: a naturalistic 6-month study.
Topics: Adult; Antidepressive Agents, Tricyclic; Depressive Disorder; Female; Humans; Male; Mianserin; Middl | 2005 |
Combining mirtazapine and duloxetine in treatment-resistant depression improves outcomes and sexual function.
Topics: Adrenergic Uptake Inhibitors; Adult; Depressive Disorder, Major; Drug Resistance; Drug Therapy, Comb | 2008 |
Mianserin, a 5-HT2a/2c and alpha 2 antagonist, in the treatment of sexual dysfunction induced by serotonin reuptake inhibitors.
Topics: Adrenergic alpha-Antagonists; Adult; Humans; Male; Mianserin; Middle Aged; Orgasm; Penile Erection; | 1997 |
Sexual dysfunction associated with mirtazapine: a case report.
Topics: Adult; Antidepressive Agents, Tricyclic; Depressive Disorder; Female; Humans; Male; Mianserin; Mirta | 1998 |
Sexual functioning in depressed outpatients taking mirtazapine.
Topics: Adult; Ambulatory Care; Depressive Disorder, Major; Ejaculation; Female; Humans; Male; Mianserin; Mi | 1999 |
Clinical pharmacology of mirtazapine: revisited.
Topics: Agranulocytosis; Antidepressive Agents, Tricyclic; Anxiety; Depression; Humans; Mianserin; Mirtazapi | 1999 |
Relief of serotonin selective reuptake inhibitor induced sexual dysfunction with low-dose mianserin in patients with traumatic brain injury.
Topics: Adult; Brain Injuries; Female; Humans; Male; Mianserin; Middle Aged; Selective Serotonin Reuptake In | 2002 |